HB Investment

HB Investment Inc. is a Korean venture capital firm established on November 11, 1999, with an initial paid-in capital of KRW 10 billion. Based in Seoul, the company focuses on investing in small and medium-sized enterprises that demonstrate potential for steady growth and profitability. In addition to financial investment, HB Investment provides various consulting services to support the development of its portfolio companies. Over the years, the firm has built a diverse portfolio across multiple sectors, including gaming, entertainment, high-tech industries such as semiconductors and LCDs, as well as biotechnology and healthcare. HB Investment has also gained experience in successfully managing several partnership funds, further enhancing its capabilities in fostering business success.

Park Ha-jin

CEO

209 past transactions

Intake

Series C in 2025
Intake Foods is a company dedicated to food content development and branding, specializing in the innovation of prominent food brands. The company operates a food technology platform that aims to replace food resources with high ecological costs. It offers a diverse selection of products made from Korean grains, vegetables, fruits, and nuts, including energy bars and coffee lines enriched with vitamins and nutrients. Through its initiatives, Intake Foods seeks to promote a healthier lifestyle for consumers while fostering a culture of food innovation.

ProtoPie

Series B in 2025
ProtoPie is a software company that specializes in interactive prototyping tools, enabling designers and engineers to create sophisticated prototypes without the need for coding. Its platform allows users to transform UI and UX design concepts into highly interactive prototypes for mobile, desktop, web, and IoT applications. Recognized for its ease of use and powerful capabilities, ProtoPie is adopted by leading global brands such as Google, Microsoft, R/GA, and Ideo. The company focuses on helping designers ideate, iterate, and innovate effectively, addressing contemporary design challenges in a user-friendly manner.

MakinaRocks

Funding Round in 2024
MakinaRocks is a global AI software startup founded in 2017 and headquartered in Seoul, South Korea. The company specializes in developing enterprise solutions that leverage machine intelligence to address industry-specific challenges. Its platform focuses on analytics and performance management, offering tools for predictive maintenance, operational optimization, and anomaly detection. By combining advanced artificial intelligence model development with practical applications, MakinaRocks enables businesses to enhance productivity and operational efficiency through cost-effective automation and intelligent control.

Dnotitia

Seed Round in 2024
Dnotitia is a pioneering AI (Artificial Intelligence) company driving innovative value by integrating AI and data. Founded in October 2023, Dnotitia specializes in developing; Seahorse, a high-performance vector database powered by its proprietary Vector Data Processing Units (VDPU), and Mnemos, a cutting-edge service solution for Large Language Models (LLMs). The company also leads the development of sLMs (Small Language Models) and Retrieval-Augmented Generation (RAG) systems, crucial for advancing generative AI technologies and positioning itself at the forefront of AI technology.

Enterobiome

Series C in 2024
Enterobiome is a biopharmaceutical company focused on the development of microbiome-based therapeutics aimed at treating various human diseases. The company specializes in creating microbial products designed to address immune diseases, metabolic disorders, aging-related conditions, and cancer. Enterobiome's innovative approach seeks to enhance patient recovery and improve overall quality of life through its advanced biopharmaceutical solutions.

Lucas

Series B in 2024
Lucas develops a system to detect, measure, categorize and track nodules in the screening CT images.

Unastella

Series A in 2024
Unastella is a company focused on the development and operation of its own launch vehicles, specifically designed to provide human space travel services. It specializes in creating civilian manned space launch vehicles that facilitate quasi-orbital space travel. By advancing technology for safe and reliable manned space flights, Unastella aims to enable passengers to experience space travel in a quasi-orbital environment.

Oncosoft

Series B in 2024
Oncosoft specializes in developing software solutions aimed at enhancing anti-cancer treatment. The company offers an Oncology Information Management Solution (OIMS) and employs artificial intelligence to support radiologists in cancer detection. Their applications utilize machine learning to automate various tasks in radiation therapy, including treatment site detection and organ contour generation. By streamlining workflows for radiation oncologists, Oncosoft's technologies enable healthcare professionals to allocate more time to patient care and improve the overall efficiency of radiation therapy.

PGT

Series D in 2024
PGT is a manufacturing company that develops specialty chemicals designed to be used as industrial raw materials.

AITRICS

Series B in 2024
AITRICS is a company focused on enhancing healthcare through its innovative clinical decision support platform. By leveraging machine learning technologies and evidence-based expert analysis, AITRICS aims to improve patient outcomes by providing real-time clinical insights. The platform transforms traditional reactive disease management into a proactive approach, emphasizing predictive, preventive, personalized, and participatory care. AITRICS brings together a diverse team of professionals dedicated to democratizing access to data-driven health intelligence, ultimately striving to revolutionize the way healthcare is delivered and experienced.

Onheal

Series B in 2023
Onheal is a company based in South Korea that specializes in the veterinary sector, focusing on the development and distribution of medicines and medical devices for companion animals. The company operates a healthcare platform aimed at extending the life of pets, offering a range of animal medicines and equipment. Through veterinary research and efficacy tests, Onheal provides essential products that support the health and well-being of companion animals, enabling pet owners to access functional and healthy food options for their dogs and other pets.

MindwareWorks

Series B in 2023
MindwareWorks, established in 2017, specializes in AI-driven customer engagement solutions. It provides machine learning-based chatbots and AI contact center services, primarily serving financial institutions in Korea and Japan. The company's flagship product, CogInsight, is an enterprise conversation AI platform used by over 50 major corporations, including Hyundai-Card, KakaoPay, and various finance groups, to facilitate non-face-to-face customer interactions.

DOF

Series B in 2023
DOF specializes in regenerative medicine, including nerve conduit platforms. The company's products include allograft tissue and medical devices.

Driving Teacher

Seed Round in 2023
You may search and compare the pricing of all driving schools countrywide in Driving Teacher, and you can help students make real-time training reservations with just a few clicks without connecting to a counselor. Furthermore, it provides an online reservation management platform to driving schools in order to automate the driving school system, as well as sales growth through customized marketing.

mangrove

Venture Round in 2023
mangrove is a real estate and rental services provider.

Law&Good

Series A in 2023
Law&Good is a law and consulting firm that operates a legal platform aimed at both retail consumers and businesses. This platform facilitates the submission of requests for proposals, allowing clients to receive and compare responses from various lawyers. By doing so, Law&Good enables users to search for legal consultation and representation that is tailored to their specific needs. The firm's innovative approach streamlines the process of finding legal assistance, making it more accessible and efficient for clients seeking legal services.

Yipscell

Series B in 2022
Yipscell is a biotech company that develops IPSC stem cell therapy to diagnose and treat incurable diseases.

GB Soft

Series A in 2022
GB Soft Co., Ltd. specializes in developing non-contact measurement solutions for bio-signals, including pulse, blood pressure, oxygen saturation, and heart rate variability. These technologies facilitate basic health status checks for both daily life and medical applications. By analyzing bio-signals, GB Soft's solutions can assess fatigue, drowsiness, stress levels, and blood sugar, making them valuable across various sectors such as automotive, transportation, construction, manufacturing, and wellness. The measurement process is completed in under 10 seconds and boasts high accuracy, positioning GB Soft as a leader in this domain. The company aims to enhance daily convenience and safety through its innovative bio-signal measurement systems.

Neonesia

Series B in 2022
NeoNesia is a marketplace and software-as-a-service (SaaS) company based in Indonesia, focused on empowering small and medium enterprises (SMEs). It operates a business-to-business e-commerce platform that facilitates the buying and selling of prepaid top-ups. The platform features a prepaid charging distribution system combined with a digital payment portal, allowing customers to purchase digital products online. By streamlining the transaction process for SMEs, NeoNesia enhances their ability to engage in the digital economy and expand their product offerings.

FEROKA

Series B in 2022
Feroka is a biotechnology company focused on advancing drug delivery systems through its innovative multi-layer microneedle patch platform. This technology is designed for precise delivery of vaccines and gene therapies by using micrometer-sized needles that can effectively penetrate various skin layers, including the epidermis and dermis. The microneedles rapidly melt upon application, allowing for the easy removal of the patch while ensuring that the drug is administered in exact volumes. This approach not only facilitates the treatment of conditions such as epidermolysis bullosa but also enhances the overall convenience and efficacy of drug delivery for various medical applications.

Oncosoft

Venture Round in 2022
Oncosoft specializes in developing software solutions aimed at enhancing anti-cancer treatment. The company offers an Oncology Information Management Solution (OIMS) and employs artificial intelligence to support radiologists in cancer detection. Their applications utilize machine learning to automate various tasks in radiation therapy, including treatment site detection and organ contour generation. By streamlining workflows for radiation oncologists, Oncosoft's technologies enable healthcare professionals to allocate more time to patient care and improve the overall efficiency of radiation therapy.

ProxiHealthcare USA

Series A in 2022
ProxiHealthcare USA is a biotechnology research organization dedicated to advancing personal and environmental healthcare. The company specializes in developing bio-convergence technology aimed at enhancing human health and promoting a cleaner environment. Its product offerings include electronic and pet toothbrushes, skin cleansing products, automotive air conditioning devices, water pipe bio-film, and humidifier bio-film. By focusing on innovative solutions, ProxiHealthcare USA seeks to empower customers to lead healthier lives while addressing environmental concerns.

EnhancedBio

Series C in 2022
EnhancedBio Inc. is a biopharmaceutical company based in Seoul, South Korea, that focuses on researching and developing anti-cancer therapeutics. Founded in 2016, the company is dedicated to creating innovative treatments for cancer patients globally. Its product pipeline includes HPV siRNA therapeutics aimed at addressing various cancers linked to Human Papilloma Virus infection. In addition, EnhancedBio is developing small molecular drug candidates targeting other oncological pathways, such as PTEN, PMVK, and RRM2. By concentrating on target-specific drugs and companion diagnostics, EnhancedBio aims to enhance cancer treatment options available to healthcare professionals, ultimately improving patient outcomes.

Sharetreats

Series B in 2022
Sharetreats Innovation is a company based in Makati, Philippines, that has developed a platform enabling consumers to send and receive vouchers redeemable at select nearby branches. After a payment is completed, treat codes are delivered via SMS, facilitating a seamless gifting experience. In addition to its voucher system, Sharetreats promotes a cultural movement encouraging social interactions through casual gifts, offering a variety of stickers and greetings suitable for various events.

Bbodek

Series B in 2022
Bbodek is a Seoul-based company that provides tableware rental and washing services for restaurants and school cafeterias in Korea. It offers children's tableware and hygiene management products and operates a self-developed smart factory to deliver high-quality services, enabling clients to focus on cooking without cleanup. It is expanding into customized washing machine manufacturing and sales.

Korea Integrated Civil Service Center

Venture Round in 2022
Korea Integrated Civil Service Center is a civil service portal that streamlines the delivery of civil and copyright services. It operates a global document hub designed for issuing and certifying civil complaints, allowing users to navigate the often complex and demanding processes online. By utilizing a mobile-friendly platform, the center enables customers to efficiently apply for and manage their civil complaints, significantly reducing both time and costs associated with traditional methods. This innovative approach enhances accessibility to essential civil services, making it easier for citizens to fulfill their legal needs.

Novelty Nobility

Series B in 2022
Novelty Nobility Inc. is a private biotech company dedicated to researching novel angiogenesis targets and developing antibody-based therapeutics, particularly in the fields of ophthalmology and oncology. The company has identified Stem Cell Factor (SCF) and c-KIT as significant angiogenesis targets, which are linked to the proliferation and survival of hematopoietic stem cells. By focusing on the anti-SCF/c-KIT pathway, Novelty Nobility aims to address the unmet medical needs associated with existing anti-VEGF treatments, specifically regarding efficacy and long-term safety. The company is actively engaged in developing therapeutic antibodies and antibody-drug conjugates to combat drug resistance and the negative effects of aberrant blood vessel growth in conditions such as retinal diseases and solid tumors. Their lead candidate, NN2101, a full-human monoclonal antibody, is currently in preclinical development and is supported by strong patent protection in the United States and South Korea.

ProtoPie

Series A in 2022
ProtoPie is a software company that specializes in interactive prototyping tools, enabling designers and engineers to create sophisticated prototypes without the need for coding. Its platform allows users to transform UI and UX design concepts into highly interactive prototypes for mobile, desktop, web, and IoT applications. Recognized for its ease of use and powerful capabilities, ProtoPie is adopted by leading global brands such as Google, Microsoft, R/GA, and Ideo. The company focuses on helping designers ideate, iterate, and innovate effectively, addressing contemporary design challenges in a user-friendly manner.

Kodebox

Series B in 2022
A blockchain technology company on a mission to create and enable smarter asset management systems.

Jobis

Venture Round in 2022
Jobis is an accounting management platform by AI.

LIVEKLASS

Seed Round in 2022
LIVEKLASS is an online education platform for educators and students.

Posicube

Series B in 2021
Posicube specializes in developing advanced technologies to enhance customer service operations. The company offers big data analytics, machine learning, artificial intelligence, and CRM system development services. Additionally, Posicube has developed voice recognition technology that automates call center interactions, processes orders efficiently, and utilizes AI image recognition to extract necessary information. This technology is particularly beneficial for businesses such as restaurants and salons, streamlining their customer relation management processes.

Doongji

Seed Round in 2021
Doongji is a small company specializing in building management and maintenance services for commercial properties. It focuses on enhancing the profitability of its clients' real estate assets through effective management of estate leases, vacancy situations, and cash flow. By providing comprehensive facility management, Doongji aims to ensure that commercial properties are well-maintained and efficiently operated, thereby supporting clients in maximizing their investment returns.

Hobbyful

Series A in 2021
Hobbyful is an online platform dedicated to connecting enthusiasts with various hobbies. It offers a range of educational resources and recreational activities, featuring diverse content and instructional kits for users to engage in their chosen pastime at home. The company provides video lessons taught by experienced instructors, allowing users to develop new skills or deepen their existing ones conveniently.

Curamys

Series A in 2021
Curamys is a biotechnology company focused on developing innovative cell fusion technology aimed at treating rare and intractable diseases. The company's approach utilizes cell gene therapy to enable stem cells to identify and fuse with diseased cells, promoting healing by integrating healthy, youthful stem cells with affected cells. This technology provides healthcare professionals with advanced tools for diagnosing and treating genetic disorders that have limited treatment options, thereby addressing significant unmet medical needs in the field of healthcare.

Common Computer

Series B in 2021
Common Computer is a company based in Seoul, South Korea, focused on developing a blockchain-based open resource platform that enables individual developers to create artificial intelligence services. The company operates two main platforms: AI Network and aFan. AI Network provides an artificial intelligence architecture designed to facilitate the deployment of AI applications, operating in a peer-to-peer cloud environment. aFan serves as a decentralized application that supports this ecosystem. Common Computer aims to revolutionize the open-source landscape through its "Open Resource" initiative, which allows developers to upload programs freely while enabling resource providers to efficiently operate and monetize these applications. Additionally, the company has developed Ainize, a serverless cloud platform that supports AI Network by facilitating the integration of microservices, making it accessible not only to blockchain enthusiasts but also to those interested in open-source technologies.

Blue Farm Korea

Series B in 2021
Blue Farm Korea supplies medical consumables, medical devices, and quasi-drugs for domestic and foreign pharmaceutical companies.

Connecting

Series B in 2021
Connecting is a real-time voice-talk service company that focuses on facilitating meaningful conversations among individuals. It has developed a social calling application that allows users to define their preferences, including hobbies, age, region, and gender, to enhance the matching process. By leveraging a specialized algorithm, the application connects users with others who share similar interests and criteria, enabling them to engage in hassle-free conversations. This innovative approach aims to create a more personalized and fulfilling social interaction experience for its users.

Sizzle

Series A in 2021
Sizzle is a company that provides an integrated process analysis solution based on accumulated experience.

HMC Networks

Series B in 2021
HMC Networks Co., Ltd. is a South Korean company established in 2013, based in Seoul, that specializes in providing management, consulting, and investment services tailored for hospitals and clinics. The company operates CareNation, a caregiver matching platform designed to connect caregivers, guardians, and patients, leveraging extensive industry expertise. Additionally, HMC Networks has divisions focused on medical devices, food products, and personal and joint care services. By utilizing big data, HMC Networks aims to drive service innovation and address information imbalances within the medical sector.

AKUODIGITAL

Series B in 2021
AKUODIGITAL provides a medical chart and corporate document bulk scanning solution.

SCAI Therapeutics

Series B in 2021
SCAI Therapeutics is a biopharmaceutical company focused on developing innovative drug delivery technologies aimed at enhancing the bioavailability of therapeutic agents. By leveraging its proprietary platform, the company seeks to improve the effectiveness of pharmaceuticals, thereby providing valuable solutions for the global pharmaceutical industry. SCAI Therapeutics aims to enable clients to validate and achieve improved therapeutic outcomes through its advanced delivery systems.

Techlabs

Series A in 2021
Techlabs is an advertising technology company that offers platform development using AI.

InCerebro

Seed Round in 2021
InCerebro is a pharmaceutical research and development company that offers drug development.

Yipscell

Series A in 2021
Yipscell is a biotech company that develops IPSC stem cell therapy to diagnose and treat incurable diseases.

ESTsecurity

Private Equity Round in 2021
ESTsecurity Corp., established in 2017 and headquartered in Seoul, South Korea, specializes in developing artificial intelligence-driven cybersecurity software. The company offers a range of security solutions, including endpoint protection, Android security, threat intelligence, and hybrid virtual desktop infrastructure (VDI) security. As a subsidiary of ESTsoft Corp., ESTsecurity operates to create a safe digital environment by providing intelligent security solutions that protect against advanced cyber threats.

HOWSER

Series B in 2021
HOWSER provides furniture construction and delivery solutions through an online infrastructure based on IT technology.

Novelty Nobility

Series B in 2021
Novelty Nobility Inc. is a private biotech company dedicated to researching novel angiogenesis targets and developing antibody-based therapeutics, particularly in the fields of ophthalmology and oncology. The company has identified Stem Cell Factor (SCF) and c-KIT as significant angiogenesis targets, which are linked to the proliferation and survival of hematopoietic stem cells. By focusing on the anti-SCF/c-KIT pathway, Novelty Nobility aims to address the unmet medical needs associated with existing anti-VEGF treatments, specifically regarding efficacy and long-term safety. The company is actively engaged in developing therapeutic antibodies and antibody-drug conjugates to combat drug resistance and the negative effects of aberrant blood vessel growth in conditions such as retinal diseases and solid tumors. Their lead candidate, NN2101, a full-human monoclonal antibody, is currently in preclinical development and is supported by strong patent protection in the United States and South Korea.

Lawfully

Seed Round in 2021
Lawfully is an immigration legaltech company founded in 2017 and based in New York. The company leverages data analytics and artificial intelligence to enhance the immigration process for both immigrants and legal professionals. Lawfully offers a platform that connects immigrants with a variety of immigration service providers, facilitating access to essential services such as case tracking, case analysis, legal consultations, and mock interviews. By utilizing advanced algorithms, Lawfully delivers personalized insights regarding case processing times, approval rates, and the likelihood of requests for evidence. Through its innovative use of technology, Lawfully aims to simplify and improve the immigration experience for individuals navigating the complexities of immigration law.

Play Tango

Series A in 2021
Play Tango is a company that specializes in developing interactive learning products designed to transform children's educational experiences. Its flagship product, Tango, is a screenless smartboard that utilizes tangible blocks to facilitate learning. This innovative system allows children to construct words, numbers, and art, while providing real-time feedback on their creations. By merging physical play with technology, Play Tango aims to enhance children's learning processes, fostering a healthy foundation for future academic success.

Mommaeat

Series B in 2021
Mommaeat is a Korea based O2O shopping mart.

Jobis

Venture Round in 2021
Jobis is an accounting management platform by AI.

mangrove

Series B in 2021
mangrove is a real estate and rental services provider.

SW Chemicals

Venture Round in 2021
SW Chemicals specializes in the development and production of nano-diamond products tailored for high-value industries. The company offers a range of services, including analysis, early development, and chamber design and manufacturing. By focusing on customized nanodiamond suspensions and highly stable, concentrated paste formulations, SW Chemicals helps businesses reduce purification costs and enhance the efficiency of their processes.

Oncosoft

Venture Round in 2021
Oncosoft specializes in developing software solutions aimed at enhancing anti-cancer treatment. The company offers an Oncology Information Management Solution (OIMS) and employs artificial intelligence to support radiologists in cancer detection. Their applications utilize machine learning to automate various tasks in radiation therapy, including treatment site detection and organ contour generation. By streamlining workflows for radiation oncologists, Oncosoft's technologies enable healthcare professionals to allocate more time to patient care and improve the overall efficiency of radiation therapy.

MBI

Venture Round in 2021
MBI specializes in electric motorcycle gearboxes. MBI is a company that has held approximately 25 patents worldwide for the past 20 years through research and development of bicycle hub internal transformers and electric two-wheel motor transformers.

Spidor Craft

Venture Round in 2021
Spidor Craft is a delivery agency focused on providing fast and efficient delivery services to its clients. Specializing in connecting restaurants with consumers, the company utilizes two-wheeled transportation to enhance the speed of its deliveries. Spidor Craft aims to capture a significant market share in the last-mile delivery sector by ensuring that products reach their destinations quickly and effectively. Through its dedicated services, the company addresses the growing demand for reliable delivery solutions in the market.

Sure Mobility

Venture Round in 2021
Sure Mobility is a company that specializes in developing a cloud-based mobility platform tailored for companies offering shared electric kickboards. The platform provides essential features such as real-time tracking, GPS navigation, and payment processing. These tools enable businesses to efficiently manage their fleets and continuously gather and utilize user data, supporting the growing trend of total mobility.

InCerebro

Venture Round in 2021
InCerebro is a pharmaceutical research and development company that offers drug development.

Vaxcell Bio

Post in 2021
Vaxcell Bio Therapeutics is a biopharmaceutical company focused on developing innovative therapies for cancer treatment. The firm specializes in creating cell-based and protein-based immunotherapeutics aimed at enhancing the immune system's ability to fight cancer. By leveraging advanced biotechnological methods, Vaxcell Bio is dedicated to addressing unmet medical needs in oncology through its pipeline of anti-cancer drugs and other novel therapeutic solutions.

CoDo

Pre Seed Round in 2020
CoDo is an onboard service company that specializes in transforming traditional onboarding processes into automated, self-paced group journeys tailored for growth and success. It offers a social training platform that enhances user engagement through optimized learning experiences. CoDo's solutions cater to various sectors, including the gig economy, sharing economy, customer education, and peer-to-peer learning. Additionally, the company has developed a mobile instruction delivery platform that enables the conversion of text-based instructions into mobile-friendly card decks. These decks can be accessed via SMS or QR code, facilitating improved knowledge retention among users.

ILIAS Biologics

Series B in 2020
ILIAS Biologics is a biotechnology company focused on developing exosome-based therapeutics. The company utilizes a platform technology that allows for the loading of large therapeutic molecules into exosomes, which are naturally occurring extracellular vesicles released by cells. This innovative approach aims to provide potential treatments for sepsis, pre-term birth, and various difficult-to-treat diseases, particularly in the inflammatory and metabolic domains. By harnessing the capabilities of exosomes, ILIAS Biologics seeks to advance drug development and improve therapeutic options for patients facing these challenging health issues.

OKXE

Series A in 2020
OKXE is an online marketplace specializing in the buying and selling of motorcycles. The company connects motorcycle sellers and buyers through its e-commerce platform, which leverages artificial intelligence and big data to enhance the shopping experience. OKXE features a diverse selection of motorcycles from various brands and stores, ensuring that all listings are verified for quality and authenticity. This commitment to safety and transparency allows customers to engage in a streamlined and secure online motorbike shopping experience.

CORELINESOFT

Series B in 2020
CORELINESOFT develops medical software products.

Heuron

Seed Round in 2020
Heuron Co., Ltd. is a company specializing in AI-based medical imaging and diagnostic solutions for neurodegenerative diseases, including Parkinson's disease, Alzheimer's disease, stroke, and brain tumors. Founded by a neurologist with 15 years of experience, Heuron aims to simplify complex diagnostic challenges through innovative technology. The company develops medical AI software that enhances the diagnosis of neurological conditions by providing MR image-based tools. These solutions enable medical professionals to achieve early diagnosis, effective staging, traceability, and assessment of brain damage levels, thereby improving patient care and treatment outcomes.

MakinaRocks

Series A in 2020
MakinaRocks is a global AI software startup founded in 2017 and headquartered in Seoul, South Korea. The company specializes in developing enterprise solutions that leverage machine intelligence to address industry-specific challenges. Its platform focuses on analytics and performance management, offering tools for predictive maintenance, operational optimization, and anomaly detection. By combining advanced artificial intelligence model development with practical applications, MakinaRocks enables businesses to enhance productivity and operational efficiency through cost-effective automation and intelligent control.

Spidor Craft

Series A in 2020
Spidor Craft is a delivery agency focused on providing fast and efficient delivery services to its clients. Specializing in connecting restaurants with consumers, the company utilizes two-wheeled transportation to enhance the speed of its deliveries. Spidor Craft aims to capture a significant market share in the last-mile delivery sector by ensuring that products reach their destinations quickly and effectively. Through its dedicated services, the company addresses the growing demand for reliable delivery solutions in the market.

Odd Concepts

Series B in 2020
Odd Concepts Inc. is a technology company specializing in computer vision and artificial intelligence solutions. Founded in 2012 and based in Seoul, South Korea, it offers a comprehensive portfolio of image recognition and search technologies delivered as a cloud-based API service. The company's innovative platform is designed to meet diverse customer needs by allowing for the tuning and combination of analysis engines to achieve optimal results. Additionally, Odd Concepts develops software for video content searches, facilitating connections between offline retail businesses and online markets. This enables clients to conduct product data analysis and provide personalized product recommendations, enhancing the overall shopping experience.

HMC Networks

Series A in 2020
HMC Networks Co., Ltd. is a South Korean company established in 2013, based in Seoul, that specializes in providing management, consulting, and investment services tailored for hospitals and clinics. The company operates CareNation, a caregiver matching platform designed to connect caregivers, guardians, and patients, leveraging extensive industry expertise. Additionally, HMC Networks has divisions focused on medical devices, food products, and personal and joint care services. By utilizing big data, HMC Networks aims to drive service innovation and address information imbalances within the medical sector.

Neonesia

Series A in 2020
NeoNesia is a marketplace and software-as-a-service (SaaS) company based in Indonesia, focused on empowering small and medium enterprises (SMEs). It operates a business-to-business e-commerce platform that facilitates the buying and selling of prepaid top-ups. The platform features a prepaid charging distribution system combined with a digital payment portal, allowing customers to purchase digital products online. By streamlining the transaction process for SMEs, NeoNesia enhances their ability to engage in the digital economy and expand their product offerings.

MX Bio

Series A in 2020
MX Bio is a MedTech startup that is addressing periodontal disease, also known as gum disease, an ailment that affects approximately 11.2% of the world’s population. MX Bio has developed a suite of three complimentary solutions to help prevent periodontal disease, and to cure it once it becomes a problem: 1. A biodegradable chip that is inserted between the teeth and releases medication in a controlled manner during one week of effective, efficient treatment, killing the germs that cause periodontal disease. 2. A compound antibiotic ointment that has completed successful preclinical trials. 3. An ointment and membrane type periodontal regeneration inducer. MX Bio's solutions have been developed with ultimate efficacy in mind. The company can deliver them for around 30% of the current market price, across the product range.

ProtoPie

Series A in 2020
ProtoPie is a software company that specializes in interactive prototyping tools, enabling designers and engineers to create sophisticated prototypes without the need for coding. Its platform allows users to transform UI and UX design concepts into highly interactive prototypes for mobile, desktop, web, and IoT applications. Recognized for its ease of use and powerful capabilities, ProtoPie is adopted by leading global brands such as Google, Microsoft, R/GA, and Ideo. The company focuses on helping designers ideate, iterate, and innovate effectively, addressing contemporary design challenges in a user-friendly manner.

AdenaSoft

Venture Round in 2020
AdenaSoft is an information technology company focused on providing innovative solutions to the financial services industry. The company specializes in developing and distributing software that facilitates online operations, customer relationship management, foreign exchange trading, cryptocurrency trading, and risk management services. By integrating IT and finance, AdenaSoft enables financial institutions to operate within a streamlined and secure technological framework, enhancing their overall efficiency and effectiveness in managing various financial operations.

Value Space

Series A in 2020
Value Space Co. is a space reconstruction company that offers space-optimized services through project development planning.

Laseroptek

Venture Round in 2020
Laseroptek Co. Ltd. is a global developer and manufacturer of advanced laser equipment tailored for medical and industrial applications. Founded in 2000 and based in Seonnam-si, South Korea, the company specializes in various laser systems, including the Picolo for treating pigmented lesions, tattoo removal, scar correction, and skin rejuvenation. It also offers the Pallas, an ultraviolet laser system aimed at addressing complex skin conditions such as vitiligo and psoriasis. Other notable products include the Helios and Lotus series, the Zelos alexandrite laser system, and the Hyperion, a long pulsed laser system recognized for its stability and effectiveness.

SoVarGen

Venture Round in 2020
SoVarGen is a biotechnology company focused on developing novel therapeutics and diagnostic solutions for patients suffering from neurological diseases, particularly those associated with intractable central nervous system conditions stemming from low-level somatic mutations. The company employs differentiated research and development methods aimed at addressing the limitations of current treatments for brain diseases. By innovating in this field, SoVarGen seeks to establish a new paradigm for the development of effective therapies, enabling patients to access better treatment options in a shorter timeframe.

Posvax

Venture Round in 2020
Posvax develops prophylactic vaccines for life cycle-related diseases affecting the elderly. The company operates a biopharmaceutical company that develops vaccines and anticancer drugs.

Enterobiome

Venture Round in 2020
Enterobiome is a biopharmaceutical company focused on the development of microbiome-based therapeutics aimed at treating various human diseases. The company specializes in creating microbial products designed to address immune diseases, metabolic disorders, aging-related conditions, and cancer. Enterobiome's innovative approach seeks to enhance patient recovery and improve overall quality of life through its advanced biopharmaceutical solutions.

Curamys

Venture Round in 2020
Curamys is a biotechnology company focused on developing innovative cell fusion technology aimed at treating rare and intractable diseases. The company's approach utilizes cell gene therapy to enable stem cells to identify and fuse with diseased cells, promoting healing by integrating healthy, youthful stem cells with affected cells. This technology provides healthcare professionals with advanced tools for diagnosing and treating genetic disorders that have limited treatment options, thereby addressing significant unmet medical needs in the field of healthcare.

Dabeeo

Series A in 2019
Dabeeo Inc. is an AI technology company based in Seoul, South Korea, founded in 2012. Specializing in geospatial data, Dabeeo focuses on creating a digital twin of the Earth by utilizing AI-powered data transformation to digitize spatial information. The company offers a comprehensive mapping technology platform that enables users to manage spatial data effectively. By employing artificial intelligence and deep learning, Dabeeo provides quick access to live maps and locations, allowing for open-source map editing. This innovation enhances the quality of map data available to businesses, improving productivity and convenience across various industries.

Hummingbird Bioscience

Series B in 2019
Hummingbird Bioscience is a biotechnology company specializing in the development of novel therapeutic antibodies for oncology and immuno-oncology indications. Utilizing systems biology approaches and proprietary computational platforms, they discover and engineer innovative biotherapeutics targeting challenging disease pathways with strong biological validation. Their pipeline includes lead assets HMBD-001 (anti-HER3) and HMBD-002 (anti-VISTA), both in cancer treatment. The company has formed strategic partnerships with Cancer Research UK and Amgen, and received a product development grant from the Cancer Prevention and Research Institute of Texas.

Value Space

Series A in 2019
Value Space Co. is a space reconstruction company that offers space-optimized services through project development planning.

Curiox Biosystems

Series B in 2019
Curiox Biosystems Pte. Ltd. is a bioinstrumentation company that specializes in the development and commercialization of innovative assay platforms aimed at advancing the life sciences, drug discovery, and diagnostics. Established in 2007 and headquartered in Singapore, Curiox offers a range of products designed to enhance the efficiency and automation of bioassays, including DropArray microplates for miniaturized assays and Laminar Wash technology for automated cell processing. Its product lineup includes various washing stations, microplates, fluids, and accessories tailored for applications such as bead-based immunoassays, suspension cell assays, high-content assays, and iPS cell research. Leveraging expertise in surface chemistry and engineering, Curiox is committed to overcoming challenges in life science research through improved automation and reproducibility.

HonestFund

Series B in 2019
HonestFund Co., LTD. is a financial technology company based in Seoul, South Korea, founded in 2015. It operates an online financial platform that provides access to a diverse array of investment opportunities, including residential and commercial real estate, infrastructure financing, unsecured personal loans, and various bond investment products. The platform is designed to facilitate a transparent and efficient process for both investors and private issuers, thereby attracting significant investments from prominent financial institutions. HonestFund's unique offering allows individuals and institutional investors to engage in alternative investments, enhancing their portfolio diversification and access to capital.

True Balance

Series C in 2019
True Balance is a digital wallet operated by Balancehero India Private Limited, designed to provide a range of financial services to its users. Launched in 2014 by CEO Charlie Lee, the platform serves approximately 70 million users across India, focusing primarily on the unbanked population. True Balance enables customers to perform utility bill payments, engage in e-commerce transactions, and access essential insurance products, as well as online lending services. By offering these financial solutions, True Balance aims to enhance financial inclusion and meet the everyday money management needs of its users.

Common Computer

Series A in 2019
Common Computer is a company based in Seoul, South Korea, focused on developing a blockchain-based open resource platform that enables individual developers to create artificial intelligence services. The company operates two main platforms: AI Network and aFan. AI Network provides an artificial intelligence architecture designed to facilitate the deployment of AI applications, operating in a peer-to-peer cloud environment. aFan serves as a decentralized application that supports this ecosystem. Common Computer aims to revolutionize the open-source landscape through its "Open Resource" initiative, which allows developers to upload programs freely while enabling resource providers to efficiently operate and monetize these applications. Additionally, the company has developed Ainize, a serverless cloud platform that supports AI Network by facilitating the integration of microservices, making it accessible not only to blockchain enthusiasts but also to those interested in open-source technologies.

Crowdworks

Series B in 2019
CrowdWorks, Inc. is a South Korea-based company that operates an online crowdsourcing platform specifically designed for artificial intelligence (AI). The company focuses on enhancing machine learning processes by collecting, structuring, and strengthening training data. It provides services that include the analysis and classification of various types of data, such as images, text, audio, and survey responses. By utilizing a pool of approximately 500,000 qualified labelers, CrowdWorks aims to improve the accuracy of human-powered data, thereby streamlining the AI model training workflow. The platform's Auto-ML features facilitate efficient data preparation, making it an essential resource for over 430 leading AI companies seeking to rapidly develop and deploy advanced AI solutions.

MX Bio

Series A in 2019
MX Bio is a MedTech startup that is addressing periodontal disease, also known as gum disease, an ailment that affects approximately 11.2% of the world’s population. MX Bio has developed a suite of three complimentary solutions to help prevent periodontal disease, and to cure it once it becomes a problem: 1. A biodegradable chip that is inserted between the teeth and releases medication in a controlled manner during one week of effective, efficient treatment, killing the germs that cause periodontal disease. 2. A compound antibiotic ointment that has completed successful preclinical trials. 3. An ointment and membrane type periodontal regeneration inducer. MX Bio's solutions have been developed with ultimate efficacy in mind. The company can deliver them for around 30% of the current market price, across the product range.

Sharetreats

Series A in 2019
Sharetreats Innovation is a company based in Makati, Philippines, that has developed a platform enabling consumers to send and receive vouchers redeemable at select nearby branches. After a payment is completed, treat codes are delivered via SMS, facilitating a seamless gifting experience. In addition to its voucher system, Sharetreats promotes a cultural movement encouraging social interactions through casual gifts, offering a variety of stickers and greetings suitable for various events.

Therasid Bioscience

Series A in 2019
Therasid Bioscience develops therapies for treating non-alcoholic steatohepatitis and Alzheimer’s disease.

Otus

Series A in 2019
Otus is a healthcare institute that specializes in advanced eyecare system.

Yam table

Series A in 2019
Yam table is an online seafood market.

M.MONSTAR

Series C in 2019
M.MONSTAR is a software development firm that specializes in e-commerce solutions for fashion shopping malls.

Millie

Series C in 2019
Millie is an online book reading application.

ATTO Research

Venture Round in 2019
ATTO Research lead open networking innovations. ATTO Research is a network virtualization innovator with advanced SDN and NFV technologies. We are specialized in security-enhanced SDN control, network management, and cloud network virtualization.

ESTsecurity

Venture Round in 2019
ESTsecurity Corp., established in 2017 and headquartered in Seoul, South Korea, specializes in developing artificial intelligence-driven cybersecurity software. The company offers a range of security solutions, including endpoint protection, Android security, threat intelligence, and hybrid virtual desktop infrastructure (VDI) security. As a subsidiary of ESTsoft Corp., ESTsecurity operates to create a safe digital environment by providing intelligent security solutions that protect against advanced cyber threats.

Epichemtech

Venture Round in 2019
Epichemtech manufactures secondary battery materials, optical UV coatings, and paints.

Albit

Venture Round in 2019
Albit is a fintech company that offers part-time labor jobs.

TeloFarm

Venture Round in 2019
TeloFarm is a company focused on precision farming solutions through its innovative use of microsensors. It specializes in developing proprietary technology that allows for the implantation of needle probes into plant stems to measure key parameters such as electrical conductivity and sap flow speed with minimal disruption to the plants. This technology enables a deeper understanding of plant responses to environmental conditions, providing valuable data for farmers and agricultural industries. TeloFarm has notably achieved significant advancements in irrigation control, exemplified by demonstrating the world's first full feedback control of irrigation in hydroponics, which has led to remarkable efficiencies, including a zero drain rate and enhanced quality and quantity of produce.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.